Two mothers have filed a pair of wrongful death lawsuits against Rahway, New Jersey-based Merck alleging that the pharmaceutical company’s Gardasil vaccine killed their daughters. The suits ...

More than 200 lawsuits demand warnings on Gardasil labels about an autoimmune disease called Postural Orthostatic Tachycardia Syndrome, or POTS, and Primary Ovarian Insufficiency, or POI, which is ...

Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak discretionary spending, a move that dented its full-year forecast and ...

Gardasil raked in $1.55 billion in sales, down 17% from the fourth quarter of 2023. That's slightly below the $1.58 billion that analysts were expecting, according to StreetAccount estimates.

The science is not settled on the Gardasil HPV vaccine. Sacramento, California, March 02, 2023 (GLOBE NEWSWIRE) -- According to the Wisner Baum law firm, which represents hundreds of young men and ...

On Monday, plaintiffs’ lawyers filed their opening brief asking the U.S. Court of Appeals for the Fourth Circuit to reinstate more than 100 lawsuits alleging Merck’s HPV vaccine Gardasil ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

Sales of Gardasil, which is Merck’s top-earning product behind the megablockbuster Keytruda, started to trend flat last July, with Merck at the time blaming the issue on lower adoption in China ...

Federal judge rules in favor of Merck over Gardasil lawsuits, citing lack of evidence linking the HPV vaccine to serious conditions. Read more here. Skip to content.

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of its HPV vaccine, Gardasil, to reach $11 billion by 2030.

Q1 2025 Gardasil sales totalled $1.3bn, down from $2.2bn in Q1 2024. Excluding the impact of foreign exchange, the decline was 40%. Despite the setback in China, the company said the revenue drop ...